Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL24418

CCCC[N+](CCCC)(CCCC)CCCC.O=S(=O)([O-])[O-].[H+]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Tetrabuthylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.63
SLC22A2 O15244 1/20 0.55
TSHR P16473 2/20 0.50
ALDH1A1 P00352 1/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
ALOX12 P18054 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HIF1A Q16665 1/20 0.50
HSD17B10 Q99714 1/20 0.50
DNM1 Q05193 5/20 0.46
RECQL P46063 2/20 0.41
GLA P06280 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
EPHX2 P34913 1/20 0.41
BLM P54132 1/20 0.41
LSS P48449 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL5185312 1.00 SLC22A1 (0.63) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL317533 0.97 SLC22A1 (0.60) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL7396011 0.97 SLC22A1 (0.60) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL243898 0.97 SLC22A1 (0.67) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrahexylammonium SCHEMBL3641187 0.95 SLC22A1 (0.62) SLC22A1SLC22A2TSHRALDH1A1TP53
Sulfuric Acid SCHEMBL9792101 0.95 SLC22A1 (0.62) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL9795123 0.95 SLC22A1 (0.63) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrapentylammonium SCHEMBL6261128 0.95 SLC22A1 (0.63) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL28650062 0.95 SLC22A1 (0.63) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL20550033 0.95 SLC22A1 (0.63) SLC22A1SLC22A2TSHRALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 11513 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116925137-B Amplification preparation method of dimethyl heptyl methylphosphonate 上海再启生物技术有限公司 2026-05-19 CN claimed
US-20260132115-A1 SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF TIANJIN GUDUI BIO PHARM CO LTD (CN) 2026-05-14 US claimed
US-20260098005-A1 NON-FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS THE CHEMOURS COMPANY FC, LLC (US) 2026-04-09 US claimed
WO-2026043875-A1 SYNTHESIS OF OXEPANOPROLINES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2026-02-26 WO claimed
US-20260055219-A1 ULTRA-LOW LOSS HYDROCARBON RESIN COMPOSITION HUNTSMAN ADV MAT SWITZERLAND (CH) 2026-02-26 US claimed
EP-4695229-A1 PROCESS FOR THE PREPARATION OF 2-(PYRID-2-YLOXYMETHYL) PHENYLACETATES Corteva Agriscience LLC (US) 2026-02-18 EP claimed
US-20260014284-A1 PROCESS FOR PREPARATION OF RADIOLABELED STYRYLPYRIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF JUBILANT DRAXIMAGE INC (CA) 2026-01-15 US claimed
US-20250388596-A1 PROCESS FOR THE EXTRACTION AND PURIFICATION OF TETRODOTOXIN WEX PHARMACEUTICALS INC (CA) 2025-12-25 US claimed
US-20250368644-A1 DURLOBACTAM CRYSTALLINE FORMS DURAND REVILLE THOMAS FRANCOIS (US) 2025-12-04 US claimed
EP-4646629-A1 LIQUID CRYSTALS SWITCHABLE STACK, LIQUID CRYSTALS MIXTURE, GLAZING UNIT AND BUILDING PRODUCT Saint-Gobain Glass France (FR) 2025-11-12 EP claimed
US-4501919-A Process for the production of serine derivatives GRUPPO LEPETIT S.P.A. (IT) 1985-02-26 US claimed
EP-0045005-B1 PROCESS FOR THE PRODUCTION OF 2-(2-AMINOTHIAZOL-4-YL)-2-(SYN)-METHOXYIMINO-ACETIC ESTERS LONZA AG (CH) 1984-07-11 EP claimed
US-4459408-A Process for the preparation of 2-(5-isopropyl-5-methyl-4-oxo-2-imidazolin-2-yl)-3-quinoline-carboxylic acid and alkyl 2-trichloromethyl-3-quinoline-carboxylate intermediates therefor AMERICAN CYANAMID COMPANY (US) 1984-07-10 US claimed
EP-0037778-B1 2-(1,4-BENZODIOXANYL)-METHOXY-PROPANOL AMINES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINES PIERRE FABRE S.A. (FR) 1983-12-28 EP claimed
EP-0095096-A2 Improved method of synthesis of 1-substituted azacycloalkan-2-ones Whitby Research Incorporated (US) 1983-11-30 EP claimed
US-4396556-A REACTING A 2-HALOACETAMIDE WITH A PHOSPHONATE, PHOSPHINATE, OR PHOSPHINE OXIDE IN A TWO-PHASE LIQUID SYSTEM OCCIDENTAL RESEARCH CORPORATION (US) 1983-08-02 US claimed
US-4387007-A Process for the manufacture of an aldehyde HOFFMANN-LA ROCHE INC. (US) 1983-06-07 US claimed
EP-0004460-B1 IMPROVED SYNTHESIS OF 1,4-DIAZA-2-CYCLOALKANONE AND SUBSTITUTED DERIVATIVES THEREOF The B.F. GOODRICH Company (US) 1983-03-09 EP claimed
US-4293702-A FROM 2-ALKOXYBENZOTHIAZOLES; CATALYST OF TERTIARY AMINE, QUATERNARY AMMONIUM COMPOUND OR DIALKYL SULFATE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-10-06 US claimed
US-4242274-A DIPHENYLACETONITRILE, 1-(DIMETHYLAMINO)-2-HALOPROPANE, A BASE, WATER, A SOLVENT, AND A QUATERNARY CATALYST MALLINCKRODT, INC. (US) 1980-12-30 US claimed